Innovation takes centrestage at PharmaLytica 2015 EP News Bureau Sep 18, 2015 The innovation gallery was the key highlight of the show
Jubilant Life Sciences gets US FDA nod for anti-migraine tablets Sanjiv Das Sep 18, 2015 The company's drug is a generic version of AstraZeneca's Zomig-ZMT tablets, which is used for acute treatment of migraine…
SPDS conducts 3rd Annual International Convention Disso India 2015 EP News Bureau Sep 18, 2015 Event promotes introduction of new technology, innovation, deliberates on various issues related to dissolution
Improving blood sugar control could help prevent dementia in patients with type II diabetes: Study Sanjiv Das Sep 18, 2015 Researchers identified all patients with type II diabetes and no known hospitalisation for dementia who were registered in the…
Changing production strategies: New challenges in sterile filling EP News Bureau Sep 18, 2015 Sieghard Schuchmann, Managing Director — OPTIMA pharma, elaborates on the new system concepts for dosing and packaging processes,…
MeasureTest Corporation launches advanced 100 LPM airborne particle counter EP News Bureau Sep 18, 2015 MeasureTest Corporation has launched Lighthouse USA Model 3350, which can measure down To 0.3 Micron @ 100 Lpm flow rate
‘The grant award provides an important level of validation to our work’ EP News Bureau Sep 18, 2015 Botanisol, was awarded an NIH/ NCCIM grant to develop a new anti-inflammatory and possible Non-Steroidal Anti-Inflammatory Drug…
Myth vs reality of stem cell-based products EP News Bureau Sep 18, 2015 With stem cell therapy set to become an acknowledged treatment alternative globally for unmet medical diseases, BN Manohar,…
Pharma market overview: The expanding role of India and Indian companies EP News Bureau Sep 18, 2015 Maneesh Chandra, India Business Consulting Head - ZS Associates, elaborates on how the evolving global and domestic market…
Antisense RNAi therapeutics deals value approached $5.6 billion in landmark 2014: GlobalData EP News Bureau Sep 18, 2015 The figure almost triple that of the previous year, with just over $1.9 billion raised from 62 deals in 2013